TrialJCI insight2021
miR-122 promotes virus-induced lung disease by targeting SOCS1.
Adam M Collison et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
TrialJCI insight2021
Adam M Collison et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.